BioCentury | Mar 9, 2017
Finance
Pharmas learn their A, B, seeds
...for innovation. Last year, the fund participated in an $8.6 million series A round for ImmuneXcite Inc....
...Galecto Biotech AB, Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. HepaRegenix GmbH, Ulm, Germany ImmuneXcite Inc....
...Galecto Biotech AB, Copenhagen, Denmark GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. HepaRegenix GmbH, Ulm, Germany ImmuneXcite Inc....